Life expectancy among HIV-positive patients in Rwanda: A retrospective observational cohort study

The Lancet Global Health

Volumn 3, Issue 3, 2015, Pages e169-e177

  Nsanzimana, Sabin ^a   Remera, Eric ^a   Kanters, Steve ^b,c   Chan, Keith ^b   Forrest, Jamie I ^b,c   Ford, Nathan ^d   Condo, Jeanine ^e   Binagwaho, Agnes ^f,g   Mills, Edward J ^b,e  

^a RWANDA BIOMEDICAL CENTER   (Rwanda)

^b Global Evaluative Sciences   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF RWANDA   (Rwanda)

^f Rwandan Ministry of Health   (Rwanda)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RWANDA; SCALE UP; SENSITIVITY ANALYSIS; VIRUS LOAD; YOUNG ADULT; EPIDEMIOLOGY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE TABLE; SEX DIFFERENCE; VIROLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LIFE EXPECTANCY; LIFE TABLES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RWANDA; SEX FACTORS; YOUNG ADULT;

EID: 84925265869     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(14)70364-X     Document Type: Article

References (25)

1. McGuire AL, Barer JM, Montaner JS, Hogg RS There and back again: the impact of adult HIV prevalence on national life expectancies. HIV Med 2005, 6:57-58.
2. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008, 372:293-299. The Antiretroviral Therapy Cohort Collaboration.
3. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 2011, 155:209-216.
4. Binagwaho A, Farmer PE, Nsanzimana S, et al. Rwanda 20 years on: investing in life. Lancet 2014, 384:371-375.
5. Global update on HIV treatment 2013: results, impact and opportunities WHO, (accessed May 29, 2014). http://www.who.int/hiv/pub/progressreports/update2013/en/.
6. Doherty M, Ford N, Vitoria M, Weiler G, Hirnschall G The 2013 WHO guidelines for antiretroviral therapy: evidence-based recommendations to face new epidemic realities. Curr Opin HIV AIDS 2013, 8:528-534.
7. Nsanzimana S. Benefits of the implementation of the 2013 WHO guidelines on HIV treatment in combination with a test-and-treat strategy for key populations in Rwanda. International Treatment as Prevention Workshop; Vancouver, BC, Canada; April 4, 2014.
8. Chiang CL On constructing current life tables. J Am Stat Assoc 1972, 67:538-541.
9. Eayres D, Williams ES Evaluation of methodologies for small area life expectancy estimation. J Epidemiol Community Health 2004, 58:243-249.
10. Brinkhof MW, Pujades-Rodriguez M, Egger M Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 2009, 4:e5790.
11. Egger M, Spycher BD, Sidle J, et al. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS Med 2011, 8:e1000390.
12. Geng EH, Emenyonu N, Bwana MB, Glidden DV, Martin JN Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 2008, 300:506-507.
13. Romeder JM, McWhinnie JR Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning. Int J Epidemiol 1977, 6:143-151.
14. Global health observatory data repository WHO, (accessed May 29, 2014). http://apps.who.int/gho/data/node.country.country-RWA.
15. Johnson LF, Mossong J, Dorrington RE, et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 2013, 10:e1001418.
16. Bor J, Herbst AJ, Newell ML, Barnighausen T Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 2013, 339:961-965.
17. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013, 8:e81355.
18. Fox MP, Rosen S Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-09: systematic review. Trop Med Int Health 2010, 15(suppl 1):1-15.
19. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet Infect Dis 2014, 14:281-290. for the HPTN 052-ACTG Study Team.
20. Lundgren JD, Babiker AG, Gordin FM, Borges AH, Neaton JD When to start antiretroviral therapy: the need for an evidence base during early HIV infection. BMC Med 2013, 11:148.
21. De Cock KM, El-Sadr WM When to start ART in Africa-an urgent research priority. N Engl J Med 2013, 368:886-889.
22. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365:493-505.
23. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med 2011, 365:1492-1501.
24. Ford N, Meintjes G, Pozniak A, et al. The future role of CD4 cell count for monitoring antiretroviral therapy. Lancet Infect Dis 2015, 15:241-247.
25. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009, 373:48-57.